孙伟正治疗低危型骨髓增生异常综合征经验

Sun Weizheng’s Experience in Treatment of Low-Risk Myelodysplastic Syndrome

孙伟正教授从事临床与科研工作50余年,积累了极为丰富的经验,在低危型骨髓增生异常综合征(MDS)的治疗、用药方面有着独到的见解,孙教授认为低危型MDS无论在病因病机上还是在临床表现上都与慢性再生障碍性贫血相近,因此在治疗上应参照慢性再障的治疗原则,以滋阴补肾健脾生血为主。

Professor Sun Weizheng has been engaged in clinical and scientific research for more than 50 years and has accumulated abundant experience.He has unique opinions on the treatment and medication of low-risk myelodysplastic syndrome(MDS).Professor Sun believes that low-risk MDS is associated with chronic regeneration in etiology,pathogenesis and clinical manifestations,so the treatment of MDS should be based on the principle of nourishing yin,invigorating kidney,invigorating spleen and promoting blood circulation.